Cite
Pharmacokinetic and pharmacodynamic effects of elinogrel: results of the platelet function substudy from the intravenous and oral administration of elinogrel to evaluate tolerability and efficacy in nonurgent percutaneous coronary intervention patients (INNOVATE-PCI) trial.
MLA
Angiolillo, Dominick J., et al. “Pharmacokinetic and Pharmacodynamic Effects of Elinogrel: Results of the Platelet Function Substudy from the Intravenous and Oral Administration of Elinogrel to Evaluate Tolerability and Efficacy in Nonurgent Percutaneous Coronary Intervention Patients (INNOVATE-PCI) Trial.” Circulation. Cardiovascular Interventions, vol. 5, no. 3, June 2012, pp. 347–56. EBSCOhost, https://doi.org/10.1161/CIRCINTERVENTIONS.111.965608.
APA
Angiolillo, D. J., Welsh, R. C., Trenk, D., Neumann, F.-J., Conley, P. B., McClure, M. W., Stephens, G., Kochman, J., Jennings, L. K., Gurbel, P. A., Wójcik, J., Dabrowski, M., Saucedo, J. F., Stumpf, J., Buerke, M., Broderick, S., Harrington, R. A., & Rao, S. V. (2012). Pharmacokinetic and pharmacodynamic effects of elinogrel: results of the platelet function substudy from the intravenous and oral administration of elinogrel to evaluate tolerability and efficacy in nonurgent percutaneous coronary intervention patients (INNOVATE-PCI) trial. Circulation. Cardiovascular Interventions, 5(3), 347–356. https://doi.org/10.1161/CIRCINTERVENTIONS.111.965608
Chicago
Angiolillo, Dominick J, Robert C Welsh, Dietmar Trenk, Franz-Josef Neumann, Pamela B Conley, Matthew W McClure, Gillian Stephens, et al. 2012. “Pharmacokinetic and Pharmacodynamic Effects of Elinogrel: Results of the Platelet Function Substudy from the Intravenous and Oral Administration of Elinogrel to Evaluate Tolerability and Efficacy in Nonurgent Percutaneous Coronary Intervention Patients (INNOVATE-PCI) Trial.” Circulation. Cardiovascular Interventions 5 (3): 347–56. doi:10.1161/CIRCINTERVENTIONS.111.965608.